Details of Disease

General Information of Disease (ID: DIS4GB9P)

Disease Name Thymic cancer
Synonyms
tumour of thorax; tumor of thorax; thorax neoplasm; thoracic tumour; thoracic tumor; thorax cancer; thoracic segment of trunk cancer; malignant tumour of thorax; malignant tumour of the thorax; malignant tumor of thorax; malignant tumor of the thorax; malignant thoracic tumour; malignant thoracic tumor; malignant thoracic segment of trunk neoplasm; malignant thoracic neoplasm; malignant neoplasm of thorax; malignant neoplasm of thoracic segment of trunk; malignant neoplasm of the thorax; cancer of thoracic segment of trunk
Disease Class 2C27: Thymoma
Definition A primary or metastatic malignant neoplasm affecting the tissues of the thorax.
Disease Hierarchy
DISAT1Z9: Advanced cancer
DIS9SBJX: Neoplasm of thorax
DIS4GB9P: Thymic cancer
ICD Code
ICD-11
ICD-11: 2C27
ICD-10
ICD-10: C37
Expand ICD-11
'XH3734
Expand ICD-9
164.0,212.6
Disease Identifiers
MONDO ID
MONDO_0003274
UMLS CUI
C0153661
MedGen ID
56320
SNOMED CT ID
188361007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
PHA848125 DMS2Q9G Phase 2 Small molecular drug [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 69 Patented Agent(s)
Drug Name Drug ID Highest Status Drug Type REF
3-amino-5-benzyl-substituted indazole derivative 1 DMFDURZ Patented NA [2]
Azaindazole amide derivative 1 DMJWH4B Patented NA [2]
Bicyclic heteroaryl benzamide derivative 1 DMTBWC9 Patented NA [2]
Bicyclic heteroaryl benzamide derivative 2 DM5MT4R Patented NA [2]
Bicyclic heteroaryl benzamide derivative 3 DM54EV2 Patented NA [2]
Bicyclic heteroaryl benzamide derivative 4 DMUBDYG Patented NA [2]
Bicyclic heteroaryl benzamide derivative 5 DMFOVPT Patented NA [2]
Bicyclic heteroaryl benzamide derivative 6 DMQGYWV Patented NA [2]
Bicyclic heteroaryl benzamide derivative 7 DMM1LKF Patented NA [2]
Bicyclic heteroaryl benzamide derivative 8 DMVBQJ1 Patented NA [2]
Bicyclic heteroaryl benzamide derivative 9 DMGONY4 Patented NA [2]
Five membered heterocyclic benzamide derivative 1 DMPFAST Patented NA [2]
Five membered heterocyclic benzamide derivative 2 DM4U63E Patented NA [2]
Five membered heterocyclic benzamide derivative 3 DMUS4Z0 Patented NA [2]
Imidazo pyridine derivative 1 DMCXHGW Patented NA [2]
N-(phenylpyrazolyl)benzamide derivative 1 DM0ZJX7 Patented NA [2]
N-acylpiperidine ether derivative 1 DM5GCUR Patented NA [2]
N-acylpiperidine ether derivative 2 DM02RQ4 Patented NA [2]
N-acylpiperidine ether derivative 3 DMXWE5R Patented NA [2]
N-acylpiperidine ether derivative 4 DMBUQDR Patented NA [2]
N-acylpiperidine ether derivative 5 DMQ2MKT Patented NA [2]
N-acylpiperidine ether derivative 6 DMAS01P Patented NA [2]
N-acylpiperidine ether derivative 7 DMCJR4N Patented NA [2]
N-acylpyrrolidine ether derivative 1 DMQ4ULC Patented NA [2]
N-acylpyrrolidine ether derivative 2 DMK4Y71 Patented NA [2]
PMID28270021-Compound-WO2010077680 103 DM437ZC Patented NA [2]
PMID28270021-Compound-WO2010077680 109 DMNUA21 Patented NA [2]
PMID28270021-Compound-WO2010077680 201 DMQAZMC Patented NA [2]
PMID28270021-Compound-WO2010077680 481 DM6VAS2 Patented NA [2]
PMID28270021-Compound-WO2010077680 495 DMQ9CBS Patented NA [2]
PMID28270021-Compound-WO2010077680 803 DM6TJU0 Patented NA [2]
PMID28270021-Compound-WO2010077680 811 DM47FNS Patented NA [2]
PMID28270021-Compound-WO2013009582Example16 DMVS7CJ Patented NA [2]
PMID28270021-Compound-WO2013009582Example76 DMQK4IX Patented NA [2]
PMID28270021-Compound-WO2013161919Example85-117 DM2XKTB Patented NA [2]
PMID28270021-Compound-WO2014078408Example1 DMO02EL Patented NA [2]
PMID28270021-Compound-WO2014078408Example26 DMVCBSK Patented NA [2]
PMID28270021-Compound-WO2014129431Example8-1 DMKO4ZH Patented NA [2]
PMID28270021-Compound-WO2014152663 701 DMA04P6 Patented NA [2]
PMID28270021-Compound-WO2015042088Example11 DM16URY Patented NA [2]
PMID28270021-Compound-WO2015042088Example12 DMOZHGU Patented NA [2]
PMID28270021-Compound-WO2015042088Example4 DM6KXOQ Patented NA [2]
PMID28270021-Compound-WO2016054807Example1 DMD5QEL Patented NA [2]
PMID28270021-Compound-WO2016054807Example112 DMW2ZRM Patented NA [2]
PMID28270021-Compound-WO2016054807Example71 DMREZ9I Patented NA [2]
PMID28270021-Compound-WO2016054807Example80 DMPI86D Patented NA [2]
PMID28270021-Compound-WO2016054807Example82 DM9ADSN Patented NA [2]
Pyrazolo[1,5-a]pyridine derivative 1 DMH1W89 Patented NA [2]
Pyrazolo[1,5-a]pyridine derivative 2 DMLS827 Patented NA [2]
Pyrazolo[4,3-c]pyridine derivative 1 DMHRUIZ Patented NA [2]
Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1 DMTM82B Patented NA [2]
Pyrido[3,2-d]pyrimidine derivative 2 DMRHAU4 Patented NA [2]
Pyrido[3,2-d]pyrimidine derivative 3 DM6D1XR Patented NA [2]
Pyrrolo[2,3-b]pyridine derivative 1 DMVKCQU Patented NA [2]
Pyrrolo[2,3-b]pyridine derivative 2 DM7IPWB Patented NA [2]
Pyrrolo[2,3-b]pyridine derivative 3 DMCYOL7 Patented NA [2]
Pyrrolo[2,3-d]pyrimidine derivative 3 DMTX1G4 Patented NA [2]
Pyrrolo[2,3-d]pyrimidine derivative 4 DME0WSR Patented NA [2]
Pyrrolo[3,2-c]pyridine derivative 1 DMKF8HI Patented NA [2]
Six-membered heterocyclic benzamide derivative 1 DMYFK85 Patented NA [2]
Six-membered heterocyclic benzamide derivative 2 DMX6AKV Patented NA [2]
Six-membered heterocyclic benzamide derivative 3 DMEGVD4 Patented NA [2]
Six-membered heterocyclic benzamide derivative 4 DMB0D1H Patented NA [2]
Six-membered heterocyclic benzamide derivative 5 DM0GTUH Patented NA [2]
Six-membered heterocyclic benzamide derivative 6 DMZU96C Patented NA [2]
Six-membered heterocyclic benzamide derivative 7 DM15AFI Patented NA [2]
Tri-substituted urea derivative 1 DMHGRTX Patented NA [2]
Tri-substituted urea derivative 2 DMUVPR8 Patented NA [2]
Triazolo[4,3-b]pyridazine derivative 2 DMMJ1FN Patented NA [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 69 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7938).
2 Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.Expert Opin Ther Pat. 2017 Jul;27(7):831-849.